IntelGenx Tech Corp (fka IGXT)

[DMYates82]

Do you think traders will be astute enough to realize that the CRL was basically a net positive, considering that there are no further studies required and the CRL did not have questions regarding the efficacy or safety of the drug, rather the issues outstanding were related to third-party packaging/labeling? Furthermore, IGTX and Red Hill stated that they believed the majority of the issues were already addressed in an amendment previously submitted to the FDA but has yet to be reviewed.

Overall, this feels more like a technical CRL than a doomsday CRL that require more studies. Am I crazy?